Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Tolperisone, a centrally-acting muscle relaxant: a possible cause of macular haemorrhage

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1


  1. 1.

    Tekes K1. Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant. Open Med Chem J. 2014;11:17–22.

    Article  Google Scholar 

  2. 2.

    Quasthoff S, Möckel C, Zieglgänsberger W, et al. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neurosci Ther. 2008;14:107–19.

    CAS  Article  Google Scholar 

  3. 3.

    Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain. 1996;67:417–25.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Andrew Lotery.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tsokolas, G., Almuhtaseb, H., Hanifudin, A. et al. Tolperisone, a centrally-acting muscle relaxant: a possible cause of macular haemorrhage. Eye 34, 1380–1381 (2020).

Download citation

Further reading


Quick links